We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. By pressing "Accept All" or closing out of this banner, you accept our Privacy Policy and Terms of Service, revised from time to time, and you consent to the use of all cookies and similar technologies and the sharing of information they collect with third parties. You can reject marketing cookies by pressing "Deny Optional," but we still use essential, performance, and functional cookies.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
The Zacks Consensus Estimate for revenues is pegged at $734 million, suggesting an 8.4% increase from the year-ago quarter’s actual. The top line is anticipated to have increased due to year-over-year subscription revenue growth. We believe an improved go-to-market approach that elevates VRSK’s strategic dialogue with clients, and the strength of products and solutions built on proprietary data sets have benefited subscription growth.
Our estimate for revenues from the United States is pegged at $603.5 million, implying a year-over-year rise of 8.1%. We estimate revenues from the U.K. to be $53.2 million, indicating a 7% increase from the year-ago quarter’s actual. Revenues from Other countries are expected to grow 4.6% from the year-ago quarter’s actual to $72.5 million.
The consensus estimate for the bottom line is pegged at $1.6 per share, hinting at 14.3% growth from the year-ago quarter’s reported figure. Robust top-line growth, coupled with efficient cost management, is anticipated to have improved the bottom line.
What Our Model Says About VRSK
Our proven model does not conclusively predict an earnings beat for VRSK this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Verisk Analytics has an Earnings ESP of +3.00% and a Zacks Rank of 4 (Sell) at present.
Here are a few stocks that, according to our model, have the right combination of elements to beat on earnings this time around.
CBIZ, Inc. (CBZ - Free Report) : The Zacks Consensus Estimate for the company’s fourth-quarter 2024 revenues is pegged at $350.1 million, indicating a year-over-year fall of 6.9%. The consensus mark for loss is pegged at 23 cents, whereas it incurred a loss of 26 cents per share in the year-ago quarter. It surpassed the Zacks Consensus Estimate in two of the four trailing quarters and missed in the other two, delivering a negative average earnings surprise of 2%.
CBZ has an Earnings ESP of +12.00% and a Zacks Rank of 3 at present.
The company is scheduled to declare its fourth-quarter 2024 results on Feb. 26.
Accenture (ACN - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter fiscal 2025 revenues is pegged at $16.6 billion, indicating year-over-year growth of 5.2%. For earnings, the consensus mark is pegged at $2.84, suggesting a 2.5% rise from the year-ago quarter’s reported figure. The company beat the consensus estimate in three of the past four quarters and missed once, with an average surprise of 2.7%.
ACN has an Earnings ESP of +12.16% and a Zacks Rank of 3 at present.
The company is scheduled to declare its second-quarter fiscal 2025 results on March 20.
Zacks' 7 Best Strong Buy Stocks (New Research Report)
Valued at $99, click below to receive our just-released report predicting the 7 stocks that will soar highest in the coming month.
Image: Bigstock
Verisk Set to Report Q4 Earnings: Here's What You Should Know
Verisk (VRSK - Free Report) is scheduled to release its fourth-quarter fiscal 2024 results on Feb. 26, before market open.
See Zacks Earnings Calendar to stay ahead of market-making news.
VRSK surpassed the Zacks Consensus Estimate in three of the four trailing quarters and missed once, delivering an average earnings surprise of 4.2%.
Verisk Analytics, Inc. Price, Consensus and EPS Surprise
Verisk Analytics, Inc. price-consensus-eps-surprise-chart | Verisk Analytics, Inc. Quote
Verisk Analytics’ Q4 Expectations
The Zacks Consensus Estimate for revenues is pegged at $734 million, suggesting an 8.4% increase from the year-ago quarter’s actual. The top line is anticipated to have increased due to year-over-year subscription revenue growth. We believe an improved go-to-market approach that elevates VRSK’s strategic dialogue with clients, and the strength of products and solutions built on proprietary data sets have benefited subscription growth.
Our estimate for revenues from the United States is pegged at $603.5 million, implying a year-over-year rise of 8.1%. We estimate revenues from the U.K. to be $53.2 million, indicating a 7% increase from the year-ago quarter’s actual. Revenues from Other countries are expected to grow 4.6% from the year-ago quarter’s actual to $72.5 million.
The consensus estimate for the bottom line is pegged at $1.6 per share, hinting at 14.3% growth from the year-ago quarter’s reported figure. Robust top-line growth, coupled with efficient cost management, is anticipated to have improved the bottom line.
What Our Model Says About VRSK
Our proven model does not conclusively predict an earnings beat for VRSK this time around. The combination of a positive Earnings ESP and a Zacks Rank #1 (Strong Buy), 2 (Buy) or 3 (Hold) increases the odds of an earnings beat. But that is not the case here. You can uncover the best stocks before they are reported with our Earnings ESP Filter.
Verisk Analytics has an Earnings ESP of +3.00% and a Zacks Rank of 4 (Sell) at present.
You can see the complete list of today’s Zacks #1 Rank stocks here.
Stocks to Consider
Here are a few stocks that, according to our model, have the right combination of elements to beat on earnings this time around.
CBIZ, Inc. (CBZ - Free Report) : The Zacks Consensus Estimate for the company’s fourth-quarter 2024 revenues is pegged at $350.1 million, indicating a year-over-year fall of 6.9%. The consensus mark for loss is pegged at 23 cents, whereas it incurred a loss of 26 cents per share in the year-ago quarter. It surpassed the Zacks Consensus Estimate in two of the four trailing quarters and missed in the other two, delivering a negative average earnings surprise of 2%.
CBZ has an Earnings ESP of +12.00% and a Zacks Rank of 3 at present.
The company is scheduled to declare its fourth-quarter 2024 results on Feb. 26.
Accenture (ACN - Free Report) : The Zacks Consensus Estimate for the company’s second-quarter fiscal 2025 revenues is pegged at $16.6 billion, indicating year-over-year growth of 5.2%. For earnings, the consensus mark is pegged at $2.84, suggesting a 2.5% rise from the year-ago quarter’s reported figure. The company beat the consensus estimate in three of the past four quarters and missed once, with an average surprise of 2.7%.
ACN has an Earnings ESP of +12.16% and a Zacks Rank of 3 at present.
The company is scheduled to declare its second-quarter fiscal 2025 results on March 20.